MLchartDataset catalogue

gemcitabine-Tarceva regimen

Term · Oncology and biomedicine · MLC-T-ONC-003463

A chemotherapy combination used for the treatment of locally advanced and metastatic pancreatic cancer. It includes the drugs gemcitabine hydrochloride and erlotinib hydrochloride. Also called gemcitabine-erlotinib regimen.

Table 1. Record
IdentifierMLC-T-ONC-003463
FieldOncology and biomedicine
Synonymsgemcitabine-erlotinib regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-003463",
  "term": "gemcitabine-Tarceva regimen",
  "field": "Oncology and biomedicine",
  "definition": "A chemotherapy combination used for the treatment of locally advanced and metastatic pancreatic cancer. It includes the drugs gemcitabine hydrochloride and erlotinib hydrochloride. Also called gemcitabine-erlotinib regimen.",
  "synonyms": [
    "gemcitabine-erlotinib regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/gemcitabine-tarceva-regimen/"
}

Record 7,877 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.